UB Paderborn / Katalog / Suche / in CDI

Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications

Nature communications, 2019-03, Vol.10 (1), p.1333-12, Article 1333

2019

Volltextzugriff (PDF)

Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2 , in Malignant Pleural Mesothelioma

Clinical cancer research, 2017-06, Vol.23 (12), p.3191-3202

2017

Volltextzugriff (PDF)

Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?

Particle and fibre toxicology, 2009-06, Vol.6 (16), p.16-16

2009

Volltextzugriff (PDF)

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival

Molecular oncology, 2020-06, Vol.14 (6), p.1207-1223

2020

Volltextzugriff (PDF)

The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models

Frontiers in oncology, 2020-03, Vol.10, p.388-388

2020

Volltextzugriff (PDF)

Mesotheliomas in Genetically Engineered Mice Unravel Mechanism of Mesothelial Carcinogenesis

International journal of molecular sciences, 2018-07, Vol.19 (8), p.2191

2018

Volltextzugriff (PDF)

Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans

Critical reviews in toxicology, 2017-01, Vol.47 (1), p.1-58

2017

Volltextzugriff (PDF)

Quantification of short and long asbestos fibers to assess asbestos exposure: a review of fiber size toxicity

Environmental health, 2014-07, Vol.13 (1), p.59-59, Article 59

2014

Volltextzugriff (PDF)

Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition

Clinical cancer research, 2014-03, Vol.20 (5), p.1323-1334

2014

Volltextzugriff (PDF)

The highlights of the 15th international conference of the international mesothelioma interest group – Do molecular concepts challenge the traditional approach to pathological mesothelioma diagnosis?

Lung cancer (Amsterdam, Netherlands), 2022-01, Vol.163, p.1-6

2022

Volltextzugriff (PDF)

Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma

Genome medicine, 2021-07, Vol.13 (1), p.113-113, Article 113

2021

Volltextzugriff (PDF)

Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles

Journal of toxicology and environmental health. Part B, Critical reviews, 2016-01, Vol.19 (5-6), p.151-172

2016

Volltextzugriff (PDF)

Role of Mutagenicity in Asbestos Fiber-Induced Carcinogenicity and Other Diseases

Journal of toxicology and environmental health. Part B, Critical reviews, 2011-01, Vol.14 (1-4), p.179-245

2011

Volltextzugriff (PDF)

Unraveling the cellular heterogeneity of malignant pleural mesothelioma through a deconvolution approach

Molecular & cellular oncology, 2019-07, Vol.6 (4), p.1610322-1610322

2019

Volltextzugriff (PDF)

Pathogenesis of malignant pleural mesothelioma

Respirology (Carlton, Vic.), 2005-01, Vol.10 (1), p.2-8

2005

Volltextzugriff (PDF)

Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours

Oncogene, 2003-06, Vol.22 (24), p.3799-3805

2003

Volltextzugriff (PDF)

Molecular changes in mesothelioma with an impact on prognosis and treatment

Archives of pathology & laboratory medicine (1976), 2012-03, Vol.136 (3), p.277-293

2012

Volltextzugriff (PDF)

Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma

Lung cancer (Amsterdam, Netherlands), 2018-12, Vol.126, p.15-24

2018

Volltextzugriff (PDF)

Similar Tumor Suppressor Gene Alteration Profiles in Asbestos-Induced Murine and Human Mesothelioma

Cell cycle (Georgetown, Tex.), 2005-12, Vol.4 (12), p.1862-1869

2005

Volltextzugriff (PDF)

FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder

Cancer research (Chicago, Ill.), 2003-12, Vol.63 (23), p.8108-8112

2003

Volltextzugriff (PDF)

Evaluation of the antitumoral potential of different nitric oxide-donating non-steroidal anti-inflammatory drugs (NO-NSAIDs) on human urological tumor cell lines

Cancer letters, 2005-02, Vol.218 (2), p.163-170

2005

Volltextzugriff (PDF)

Nitrosulindac (NCX 1102): A new nitric oxide-donating non-steroidal anti-inflammatory drug (NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines

The Prostate, 2004-10, Vol.61 (2), p.132-141

2004

Volltextzugriff (PDF)

Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines

Molecular cancer therapeutics, 2004-03, Vol.3 (3), p.291-298

2004

Volltextzugriff (PDF)

Growth, Differentiation and Senescence of Normal Human Urothelium in an Organ-Like Culture

European urology, 2004-06, Vol.45 (6), p.799-805

2004

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications

Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2 , in Malignant Pleural Mesothelioma

Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival

The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models

Mesotheliomas in Genetically Engineered Mice Unravel Mechanism of Mesothelial Carcinogenesis

Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans

Quantification of short and long asbestos fibers to assess asbestos exposure: a review of fiber size toxicity

Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition

The highlights of the 15th international conference of the international mesothelioma interest group – Do molecular concepts challenge the traditional approach to pathological mesothelioma diagnosis?

Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma

Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles

Role of Mutagenicity in Asbestos Fiber-Induced Carcinogenicity and Other Diseases

Unraveling the cellular heterogeneity of malignant pleural mesothelioma through a deconvolution approach

Pathogenesis of malignant pleural mesothelioma

Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma

Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours

Molecular changes in mesothelioma with an impact on prognosis and treatment

Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma

Similar Tumor Suppressor Gene Alteration Profiles in Asbestos-Induced Murine and Human Mesothelioma

FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder

Evaluation of the antitumoral potential of different nitric oxide-donating non-steroidal anti-inflammatory drugs (NO-NSAIDs) on human urological tumor cell lines

Nitrosulindac (NCX 1102): A new nitric oxide-donating non-steroidal anti-inflammatory drug (NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines

Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines

Growth, Differentiation and Senescence of Normal Human Urothelium in an Organ-Like Culture

Suchergebnisse filtern